ArticleScientific reports2026
MEmilio: a high performance Modular EpideMIcs simuLatIOn software for multi-scale and comparative simulations of infectious disease dynamics.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Coupled epidemiological and wastewater modeling at the urban scale: A case study for Munich.iScience · 2026Article
- Differentially private federated learning for localized control of infectious disease dynamics.Scientific reports · 2026Article
- Graph neural network surrogates to leverage mechanistic expert knowledge towards reliable and immediate pandemic response.Scientific reports · 2026Article
- Changing socioeconomic inequalities in the incidence and case fatality rates of COVID-19 in Germany, March 2020 through May 2022: an ecological study.BMC public health · 2025Article
- Hybrid metapopulation agent-based epidemiological models for efficient insight on the individual scale: A contribution to green computing.Infectious Disease Modelling · 2025Article
- Integrating Human Mobility Models with Epidemic Modeling: A Framework for Generating Synthetic Temporal Contact Networks.Entropy (Basel, Switzerland) · 2025Article
- Novel travel time aware metapopulation models and multi-layer waning immunity for late-phase epidemic and endemic scenarios.PLoS computational biology · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
36 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Epidemic and pandemic preparedness with rapid outbreak response rely on timely, trustworthy evidence. Mathematical models are crucial for supporting timely and reliable evidence generation for public health decision-making with models spanning approaches from compartmental and metapopulation models to detailed agent-based simulations. Yet, the accompanying software ecosystem remains fragmented across model types, spatial resolutions, and computational targets, making models harder to compare, extend, and deploy at scale. Here we present MEmilio, a modular, high-performance framework for epidemic simulation that harmonizes the specification and execution of diverse dynamic epidemiological models within a unified and harmonized architecture. MEmilio couples an efficient C++ simulation core with coherent model descriptions and a user-friendly Python interface, enabling workflows that run on laptops as well as high-performance computing systems. Standardized representations of space, demography, and mobility support straightforward adaptations in resolution and population size, facilitating systematic inter-model comparisons and ensemble studies. The framework integrates readily with established tools for uncertainty quantification and parameter inference, supporting a broad range of applications from scenario exploration to calibration. Finally, strict software-engineering practices, including extensive unit and continuous integration testing, promote robustness and minimize the risk of errors as the framework evolves. By unifying implementations across modeling paradigms, MEmilio aims to lower barriers to reuse and generalize models, enable principled comparisons of implicit assumptions, and accelerate the development of novel approaches that strengthen modeling-based outbreak preparedness.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.